| Variable |
Time |
Result |
Group A |
Group B |
P-value |
| N (%) |
N (%) |
| Sputum microscopy |
Baseline |
Negative |
20 (36.4) |
25 (50.0) |
0.16 |
| N=105 |
Positive |
11 (20.0) |
12 (24.0) |
| |
Not applicable |
24 (43.6) |
13 (26.0) |
| 2 months |
Negative |
18 (36.0) |
21 (42.9) |
0.46 |
| N=99 |
Positive |
02 (4.0) |
04 (8.2) |
| |
Not applicable |
30 (60.0) |
24 (48.9) |
| 6 months |
Negative |
15 (30.6) |
20 (41.7) |
0.5 |
| N=97 |
Positive |
02 (4.1) |
01 (2.1) |
| |
Not applicable |
32 (65.3) |
27 (56.2) |
| Sputum Culture |
Baseline |
Negative |
21 (38.2) |
27 (54.0) |
0.05 |
| N=105 |
Positive |
07 (12.7) |
10 (20.0) |
| |
Not applicable |
27 (49.1) |
13 (26.0) |
| 2 months |
Negative |
15 (30.0) |
20 (40.8) |
0.41 |
| N=99 |
Positive |
04 (8.0) |
05 (10.2) |
| |
Not applicable |
31 (62.0) |
24 (49.0) |
| 6 months |
Negative |
13 (26.5) |
20 (41.7) |
0.34 |
| N=97 |
Positive |
02 (4.1) |
01 (2.1) |
| |
Not applicable |
34 (69.4) |
27 (56.3) |
| Chest Plain Radiograph |
Baseline |
No active disease |
09 (16.4) |
09 (18.0) |
0.61 |
| N=105 |
Active disease |
41 (74.6) |
39 (78.0) |
| |
Not assessable |
05 (9.1) |
02 (4.0) |
| 2 months |
No active disease |
25 (50.0) |
21 (43.8) |
0.5 |
| N=98 |
Active disease |
18 (36.0) |
23 (47.9) |
| |
Not assessable |
7 (14.0) |
04 (8.3) |
| 6 months |
No active disease |
41 (83.7) |
35 (74.5) |
0.46 |
| N=96 |
Active disease |
04 (8.2) |
08 (17.0) |
| |
Not assessable |
04 (8.2) |
04 (8.5) |
| CT Scan |
Baseline |
No active disease |
0 (0.0) |
0 (0.0) |
1 |
| N=62 |
Active disease |
34 (97.1) |
27 (100.0) |
| |
Not assessable |
1 (2.9) |
0 (0.0) |
| 6 months |
No active disease |
21 (63.6) |
14 (50.0) |
0.46 |
| N=61 |
Active disease |
8 (24.3) |
11 (39.3) |
| |
Not assessable |
04 (12.1) |
03 (10.7) |
| Composite |
6 months |
Inadequate response |
10 (20.4) |
14 (29.2) |
0.24 |
| Radiological Outcome |
N=97 |
Adequate response |
32 (65.3) |
32 (66.7) |
| |
|
Not assessable |
07 (14.3) |
02 (4.3) |
|
